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INTRODUCTION {#s1}
============

Worldwide, chronic liver diseases are among the common causes of morbidity and mortality in adults over the age of 15.^[@R01]^ They are characterized by a long pre-clinical course and may take more than two decades to develop to cirrhosis. Early detection of liver diseases, appropriate treatment and life style modification may cause regression in liver fibrosis.^[@R02]^ Serum alanine aminotransferase (ALT) is an enzyme that transfers an amino group from alanine to ketoglutarate and catalyzes the formation of acid pyruvic and glutamate. It is a sensitive marker for hepatocellular damage and the most common marker used to assess hepatocellular injury.^[@R03]-[@R06]^ This study assesses the causes for elevated ALT levels in 100 consecutive patients who presented to clinics in two hospitals in Northeastern Iran.

MATERIALS AND METHODS {#s2}
=====================

This is a one year cross-sectional study on 100 consecutive patients over the age of 14 years that referred to the Gastroenterology (GI) Clinics of Ghaem and Imam Reza Hospitals at Mashhad University of Medical Sciences. All patients whose ALT levels were above normal (≥ 40 U/L), at least twice, during at least six months were enrolled. A full history that included demographics, history of alcohol consumption (amount and duration), history of drug use particularly over the previous three months prior to study entry, transfusion of blood products, tattoos, suspected sexual activity, jaundice, traveling, surgery, and any dental procedures, previous history of liver disease, diabetes, hyperlipidemia, thyroid disease, and family history of liver diseases were recorded for all patients. A complete physical examination and measurement of height and weight were performed. Body mass index (BMI) was calculated by dividing the patient's weight (kg) by height (m^2^) and classified according to the National Institute of Heart, Lung and Blood in the United States of America as follows: \<18.5 kg/m^2^ (underweight), 18.5-24.9 kg/m^2^ (normal weight), 25-29.9 kg/m^2^ (overweight) and ≥30 kg/m^2^ (obese).

Initial lab tests included fasting blood sugar (FBS), partial thrombin time(PTT), prothrombin time-international normalized ratio \[PT (INR)\], CBC (diff), cholesterol \[low density lipoprotein (LDL) and high density lipoprotein (HDL), triglycerides\], markers of viral hepatitis C and B (HBsAg, anti-HBc, anti-HCV) and liver ultrasound. Tests for other liver diseases were performed when necessary and included the following: autoimmune hepatitis \[anti-nuclear antibody (ANA), smooth muscle antibody (SMA), serum protein electrophoresis, anti-liver kidney mitochondrial antibody (anti-LKM)\]; primary biliary cirrhosis (PBC) \[anti-mitochondrial antibody (AMA)\]; hemochromatosis (serum iron, total iron binding capacity, iron saturation, ferritin); Wilson in patients \<40 years of age (serum ceruloplasmin, 24-hour urine copper); and α1--antitrypsin deficiency \[serum protein electrophoresis (phenotype)\].

Causes for non-hepatic increases in ALT levels such as celiac disease \[anti-tissue transglutaminase antibody or anti-tTG (IgA)\] were assessed. When positive, a biopsy of the second part of the duodenum was performed. Thyroid disorders (TSH) and muscle diseases (creatine kinase) were also analyzed.

If necessary, according to the results of the initial tests, additional studies were requested. In cases of positive HBsAg, patients were also tested for HBeAg, anti-HBe, and HBV-DNA. For cases of positive HCV-RNA, anti-HCV and HCV genotype analyses were performed.

NAFLD was diagnosed based on ultrasound findings of fatty liver, evidence of metabolic syndrome and/or diabetes, and dyslipidemia if other studies were negative. Liver biopsy and histopathologic examination of liver tissue required for definitive diagnosis was performed on 12 patients after obtaining their consent. In the other cases, diagnosis was based according to patient history, physical examination and clinical laboratory analyses. For increased accuracy all tests were conducted in one laboratory affiliated with the School of Medicine with the use of one kit. Ultrasonography was performed by a skilled sonographer and histological slides were reviewed by one pathologist.

RESULTS {#s3}
=======

Of the 100 participants, there were 38 males and 62 females. Mean age of patients was 44.4 ± 11.83 years. NAFLD was the cause of persistent ALT elevation in 52% of patients. Hepatitis B and autoimmune hepatitis were the second and third causes, respectively. Other causes for elevated ALT levels are shown in [Figure 1](#F01){ref-type="fig"}.
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[Tables 1](#T1){ref-type="table"}[-](#T2){ref-type="table"}[3](#T3){ref-type="table"} show demographic characteristics, laboratory analyses and BMI of the study patients.

###### Frequencies for causes of persistent elevations in ALT levels according to gender.

  ------------------------------------------- ------------- ---------------- ------------- ------ ----------
  **Etiology**                                **Gender**    *p* **-value**                        
  **Female**                                  **Male**                                            
  **Number**                                  **Percent**   **Number**       **Percent**          
  (Non Alcoholic Fatty Liver Disease) NAFLD   16            42.1             36            58.1   \< 0.001
  NAFLD+ hepatitis B                          0             0                3             4.8    
  Hepatitis B                                 1             2.6              13            21     
  Hepatitis B+D                               0             0                3             4.8    
  Hepatitis C                                 2             5.3              2             3.2    
  Autoimmune hepatitis (AIH)                  12            31.6             1             1.6    
  AIH+ hepatitis C                            0             0                2             3.2    
  Overlap                                     2             5.3              0             0      
  Wilson                                      1             2.6              0             0      
  Celiac                                      0             0                1             1.6    
  Alcoholic                                   0             0                1             1.6    
  Primary biliary cirrhosis                   1             2.6              0             0      
  Primary sclerosing cholangitis              1             2.6              0             0      
  Cryptogenic                                 2             5.3              0             0      
  Total                                       38            100              62            100    
  ------------------------------------------- ------------- ---------------- ------------- ------ ----------

###### Causes of ALT elevation according to age groups.

  ---------------------- ----------------- ---------------- ------------- ------------ ------------- ----- -------
  **Etiology**           **Age groups**    *p* **-value**                                                  
  **\<40 years**         **40-60 years**   **\>60 years**                                                  
  **Number**             **Percent**       **Number**       **Percent**   **Number**   **Percent**         
  NAFLD                  23                62.2             26            44.8         3             60    0.890
  NAFLD+ hepatitis B     1                 2.7              2             3.7          0             0     
  Hepatitis B            5                 13.5             8             13.8         1             20    
  Hepatitis B+D          0                 0                3             5.2          0             0     
  Hepatitis C            0                 0                4             6.9          0             0     
  Autoimmune hepatitis   6                 12.6             6             10.3         1             20    
  AIH+ hepatitis C       0                 0                2             3.4          0             0     
  Overlap                0                 0                2             3.4          0             0     
  Wilson                 1                 2.7              0             0            0             0     
  Celiac                 0                 0                1             1.7          0             0     
  Alcoholic              0                 0                1             1.7          0             0     
  PBC                    0                 0                1             1.7          0             0     
  PSC                    0                 0                1             1.7          0             0     
  Cryptogenic            1                 2.7              1             1.7          0             0     
  Total                  37                100              58            100          5             100   
  ---------------------- ----------------- ---------------- ------------- ------------ ------------- ----- -------

###### Frequencies of causes of ALT elevation according to body mass index (BMI).

  ---------------------- --------------- ------------- ------------- ------------ ------------- ------------ ------------- ------
  **Etiology**           **BMI**                                                                                           
  **\<18.5**             **18.5-24.9**   **25-29.9**   **\>30**                                                            
  **Number**             **Percent**     **Number**    **Percent**   **Number**   **Percent**   **Number**   **Percent**   
  NAFLD                  0               0             9             24.3         23            69.7         20            71.4
  NAFLD+ hepatitis B     0               0             1             2.7          0             0            2             7.1
  Hepatitis B            0               0             9             24.3         4             12.1         1             3.6
  Hepatitis B+D          0               0             3             8.1          0             0            0             0
  Hepatitis C            0               0             2             5.4          1             3            1             3.6
  Autoimmune hepatitis   0               0             6             16.2         3             9.1          4             14.3
  AIH+ hepatitis C       0               0             2             5.4          0             0            0             0
  Overlap                1               50            0             0            1             3            0             0
  Wilson                 0               0             1             2.7          0             0            0             0
  Celiac                 0               0             1             2.7          0             0            0             0
  Alcoholic              0               0             1             2.7          0             0            0             0
  PBC                    0               0             1             2.7          0             0            0             0
  PSC                    0               0             0             0            1             3            0             0
  Cryptogenic            1               50            1             2.7          0             0            0             0
  Total                  2               100           37            100          33            100          28            100
  ---------------------- --------------- ------------- ------------- ------------ ------------- ------------ ------------- ------

There were 42.1% of female patients and 58.1% of male patients who had NAFLD. The chi square test showed a significant relationship between causes of ALT elevation and gender (*p*\<0.001).

NAFLD was present in 62.2% of patients less than 40 years of age, in 44.8% of patients between the ages of 40--60 years and in 60% of patients over the age of 60 years. The chi square test showed no significant difference between age groups (*p*=0.890).

NAFLD was found in 71.4% of patients whose BMI was over 30, 69.7% of those whose BMI ranged from 25-29.9, and in 24.3% of patients with BMI of 18.5-24.9. None of the patients with BMI \<18.5 had NAFLD.

DISCUSSION {#s4}
==========

This study determined that NAFLD was the leading cause for persistently elevated ALT levels in our patients. Several studies reported an association with fatty liver and increased serum ALT levels, even within the normal range.^[@R03],[@R04],[@R07]^ Jamali et al. reported persistently increased serum ALT levels in 43.5% (64 out of 147) of participants. In their study, elevated serum ALT levels were detected in 9.3% of patients with hepatitis B, 6.2% who had hepatitis C, and in 4.6% of patients with alcoholic hepatitis.^[@R08]^ In a study by Pourshams, NAFLD was the most common cause for the persistent increase in serum ALT levels among blood donors in Tehran.^[@R09]^ Clark et al. found that aminotransferase elevation was more frequent in males (9.3%) compared to females (6.6%). Excessive alcohol consumption, hepatitis B, C and transferrin saturation above 31% were the causes for elevated ALT levels. However the cause for increased ALT was not detected in 69% of cases. There were significantly higher ALT levels in males and females with increased BMI, increased triglycerides and fasting insulin, and lower HDL, particularly in females with type II diabetes and hypertension. A recent study showed that the most common cause of cryptogenic cirrhosis was NAFLD.^[@R10]^ In a study conducted by Zhang et al. the most important risk factor for increased ALT was non-alcoholic fatty liver disease (NAFLD) (10.79%), followed by metabolic syndrome (16.25%) or both (20.31 %). NAFLD was more frequent in females with increased age and BMI, fasting plasma glucose, triglycerides, and LDL levels, as well as lower HDL levels. Elevated ALT levels were more common in individuals from a low socioeconomic level and in males with increased triglyceride levels, with higher BMI and metabolic syndrome.^[@R11]^ In another study, Chen et al. observed that 11.4% of the study population had increased ALT levels. Possible reasons for this increase included excessive alcohol consumption (0.8%), hepatitis B virus (HBV) (28.5%), hepatitis C viruc (HCV) (13.2%), HCV and HBV (2.2%), NAFLD (33.6%), and unknown etiology (21.8%). Although etiologically the ALT increase was similar in both sexes, more males (17.3%) had evidence of increased ALT levels than females (6.1%). The prevalence of higher ALT levels in NAFLD patients was 18.1% with a positive predictive value of 33.6. The study reported NAFLD as the most common cause for increased ALT levels in Taiwan and was associated with numerous metabolic disorders.^[@R12]^

The results of our study showed that NAFLD, hepatitis B and autoimmune hepatitis were the most common causes for persistently elevated ALT levels.
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